Which funds hold NGEN?

As of 2026-Q2, 11 institutional funds reported holding NGEN (NERVGEN PHARMA CORP) in SEC 13F filings, with a combined reported value of $2.46M.

How many shares of NGEN do institutions own?

13F filers reported 1.21M shares of NGEN, worth $2.46M in aggregate at the end of 2026-Q2.

Is institutional ownership of NGEN rising or falling?

Share counts moved +147.4% versus the prior quarter — accumulation.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Home › Stocks › NGEN

NGEN — NERVGEN PHARMA CORP

Reported value held$2.46M

Funds holding (latest)11

SectorHealth Care

Funds holding (Q2 2026)11

Institutional value$2.46M · 1.21M sh

New / Add / Cut / Exit6 / 3 / 1 / 0

Top-5 / Top-10 concentration91.9% / 100.0%

Institutional holdings change Accumulating +147.4% (+722.23K sh)

Institutional value change Up +37.7%

As of Q2 2026, 11 SEC-registered investment managers reported holding NGEN (NERVGEN PHARMA CORP) in their latest 13F filings, with a combined reported value of $2.46M across 1.21M shares. That is +147.4% by share count (+722.23K shares) versus the previous quarter, while reported value moved +37.7%. Ownership is concentrated: the five largest holders account for 91.9% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 6 opened new positions, 3 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

NGEN is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Q2 2026 — 11 funds

Fund	Shares	Value	Portfolio Weight	Change
Marshall Wace history	435.96K	$898.08K	0.00%	Add
UBS Group AG history	379.73K	$782.24K	0.00%	Add
Bank of America Corp history	186.20K	$383.57K	0.00%	Reduce
Geode Capital Management history	58.04K	$119.56K	0.00%	New
Millennium Management history	39.74K	$81.86K	0.00%	New
Citadel Advisors history	27.80K	$57.27K	0.00%	New
Wells Fargo & Co history	22.00K	$45.32K	0.00%	New
Goldman Sachs Group history	19.62K	$40.42K	0.00%	New
JPMorgan Chase & Co history	14.71K	$28.84K	0.00%	New
Morgan Stanley history	12.94K	$26.65K	0.00%	Add
T. Rowe Price Associates history	15.50K	$32	0.00%	Hold

Q1 2026 — 5 funds

Fund	Shares	Value	Portfolio Weight	Change
Bank of America Corp history	200.66K	$756.47K	0.00%	New
Marshall Wace history	200.36K	$755.36K	0.00%	New
UBS Group AG history	61.52K	$231.92K	0.00%	New
Morgan Stanley history	11.98K	$45.17K	0.00%	New
T. Rowe Price Associates history	15.50K	$59	0.00%	New

New Positions (Q2 2026)

Geode Capital Management 58.04K sh · $119.56K
Millennium Management 39.74K sh · $81.86K
Citadel Advisors 27.80K sh · $57.27K
Wells Fargo & Co 22.00K sh · $45.32K
Goldman Sachs Group 19.62K sh · $40.42K
JPMorgan Chase & Co 14.71K sh · $28.84K

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 11 funds)

Fund	Q2 2026	Q1 2026
Marshall Wace	435.96K	200.36K
UBS Group AG	379.73K	61.52K
Bank of America Corp	186.20K	200.66K
Geode Capital Management	58.04K	—
Millennium Management	39.74K	—
Citadel Advisors	27.80K	—
Wells Fargo & Co	22.00K	—
Goldman Sachs Group	19.62K	—
JPMorgan Chase & Co	14.71K	—
Morgan Stanley	12.94K	11.98K
T. Rowe Price Associates	15.50K	15.50K

Download holders (CSV)